JON FOX: Open Payments
NPI 1447221932 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 60 payments from 11 companies in 2025. Trend: 2023 $708 · 2024 $566 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $422 |
| Amgen Inc. | 5 | $166 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $139 |
| PFIZER INC. | 3 | $63 |
| Stryker Corporation | 1 | $41 |
| Abbott Laboratories | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: VRAYLAR, BIJUVA, ELIQUIS, UBRELVY, QULIPTA, MAKO, BOTOX, FREESTYLE LIBRE 3.
Industry payments across ID — which companies pay providers there.
